SCHEMBL23653656

SCHEMBL23653656

COCCn1cc2c(N=O)cc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC6(CCC6)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2n1

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29374255 0.93 BCL2 (0.85) BCL2
SCHEMBL19839483 0.93 BCL2 (0.85) BCL2
SCHEMBL29376973 0.91 BCL2 (0.82) BCL2
SCHEMBL20580518 0.91 BCL2 (0.82) BCL2
SCHEMBL19853624 0.86 BCL2 (0.84) BCL2
SCHEMBL20580667 0.86 BCL2 (0.78) BCL2
SCHEMBL29373371 0.86 BCL2 (0.78) BCL2
SCHEMBL29373716 0.85 BCL2 (0.84) BCL2
SCHEMBL19839927 0.85 BCL2 (0.84) BCL2
SCHEMBL20580464 0.85 BCL2 (1.00) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3672595-B1 COMBINATION PRODUCT OF BCL-2 INHIBITOR AND CHEMOTHERAPEUTIC AGENT AND USE THEREOF IN THE PREVENTION AND/OR TREATMENT OF DISEASES ASCENTAGE PHARMA SUZHOU CO LTD (CN) 2021-07-21 — — EP disclosed
Send feedback